Patent: 9,062,299
Summary for Patent: 9,062,299
| Title: | Coagulation factor IX compositions and methods of making and using same |
| Abstract: | The present invention relates to compositions comprising factor DC coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions. |
| Inventor(s): | Volker Schellenberger, Willem P. Stemmer, Nathan C. Geething, Wayne To, Joshua Silverman, Chia-Wei Wang, Benjamin Spink |
| Assignee: | Amunix Pharmaceuticals Inc |
| Application Number: | US13/392,511 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,062,299
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | RIXUBIS | coagulation factor ix (recombinant) | For Injection | 125446 | June 26, 2013 | ⤷ Start Trial | 2030-08-02 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,062,299
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2010210618 | ⤷ Start Trial |
| Australia | 2010258892 | ⤷ Start Trial |
| Australia | 2010258898 | ⤷ Start Trial |
| Australia | 2010290077 | ⤷ Start Trial |
| Australia | 2010290131 | ⤷ Start Trial |
| Brazil | 112012004094 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
